These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1501535)

  • 1. Dissociation of gadolinium chelates in mice: relationship to chemical characteristics.
    Wedeking P; Kumar K; Tweedle MF
    Magn Reson Imaging; 1992; 10(4):641-8. PubMed ID: 1501535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
    Fretellier N; Salhi M; Schroeder J; Siegmund H; Chevalier T; Bruneval P; Jestin-Mayer G; Delaloge F; Factor C; Mayer JF; Fabicki JM; Robic C; Bonnemain B; Idée JM; Corot C
    Eur J Pharm Sci; 2015 May; 72():46-56. PubMed ID: 25736527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo.
    Franano FN; Edwards WB; Welch MJ; Brechbiel MW; Gansow OA; Duncan JR
    Magn Reson Imaging; 1995; 13(2):201-14. PubMed ID: 7739361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
    Puttagunta NR; Gibby WA; Puttagunta VL
    Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
    Wedeking P; Tweedle M
    Int J Rad Appl Instrum B; 1988; 15(4):395-402. PubMed ID: 3255735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain distribution of MRI contrast media in rats after intracisternal injection.
    Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G
    J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496
    [No Abstract]   [Full Text] [Related]  

  • 9. Clearance of liposomal gadolinium: in vivo decomplexation.
    Unger EC; Fritz TA; Tilcock C; New TE
    J Magn Reson Imaging; 1991; 1(6):689-93. PubMed ID: 1823174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gd-DOTA: characterization of a new paramagnetic complex.
    Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
    Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.
    Puttagunta NR; Gibby WA; Smith GT
    Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride.
    Dean PB; Niemi P; Kivisaari L; Kormano M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S258-60. PubMed ID: 3198357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
    Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of dechelation of gadopentetate dimeglumine in rats.
    Kasokat T; Urich K
    Arzneimittelforschung; 1992 Jun; 42(6):869-76. PubMed ID: 1418049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties.
    Allard M; Doucet D; Kien P; Bonnemain B; Caillé JM
    Invest Radiol; 1988 Sep; 23 Suppl 1():S271-4. PubMed ID: 3198361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gd accumulation in tissues of healthy mice upon repeated administrations of Gadodiamide and Gadoteridol.
    Di Gregorio E; Iani R; Ferrauto G; Nuzzi R; Aime S; Gianolio E
    J Trace Elem Med Biol; 2018 Jul; 48():239-245. PubMed ID: 29773187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.